Security key
55083R203
Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)
CUSIP: 55083R203
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 6,818,719
- Total 13F value
- $60,295,418
- Share change
- +6,818,366
- Put/Call ratio
- 71%
- SEC-reported price per share
- $8.84
- Number of holders
- 62
- Value change
- +$60,292,297
- Number of buys
- 61
- Shares outstanding
- 24,390,244
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
62
Top holders
10
LYEL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Lyell Immunopharma, Inc. SEC filings
Lyell Immunopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55083R203
Recent filing periods:
Ownership snapshot
Top reported holders of LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Foresite Capital Fund IV,...
Disclosed value leader
Foresite Capital Fund IV,...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.2%
13D/G row: Foresite Capital Fund IV, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Foresite Capital Fund IV, L.P. leads the comparable SEC ownership view at 9.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Foresite Capital Fund IV, L.P.'s linked filing trail.
Comparable ownership
Top 5
Foresite Capital Fund IV, L.P.
9.2%
BlackRock, Inc.
4.5%
MWG Management Ltd.
86%
Foresite Capital Management IV, LLC
69%
Orland Properties Ltd
65%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Foresite Capital Fund IV, L.P. |
13D/G
James B. Tananbaum
|
9.2%
|
$12,766,089
27,161,892 shares
|
+$3,611,010 | 31 Mar 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
4.5%
from 13D/G
|
$6,844,206
12,721,571 shares
|
— | 31 Mar 2025 |
| MWG Management Ltd. |
13F
Company
|
86%
|
$10,847,335
20,162,332 shares
|
— | 31 Mar 2025 |
| Foresite Capital Management IV, LLC |
13F
Company
|
69%
|
$8,612,303
16,007,999 shares
|
— | 31 Mar 2025 |
| Orland Properties Ltd |
13F
Company
|
65%
|
$8,150,743
15,093,969 shares
|
— | 31 Mar 2025 |
| Decheng Capital LLC |
13F
Company
|
51%
|
$6,407,225
11,909,341 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
62
Shares
6,818,719
Rows available
62
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
67
Q2 2025 holders
62
Holder diff
-5
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend